NAV
₹51.0610
as of 29 Sept 2026
Expense Ratio
0.75%
Lumpsum returns (CAGR)
- 1Y
- +20.37%
- 3Y
- +21.71%
- 5Y
- +15.88%
- Since Inception
- +23.15%
SIP returns (XIRR)
- 1Y
- +26.73%
- 3Y
- +17.05%
- 5Y
- +19.80%
- Since Inception
- +22.11%
Returns calculated from 12 November 2018 onwards due to a structural change in the scheme on that date. Earlier NAV history is preserved but excluded from multi-year return calculations. Periods spanning this date show —.
Performance Comparison
Sectoral allocation
as of 31 Aug 2026- Pharmaceuticals & Biotechnology67.28%
- Healthcare Services20.36%
- Healthcare Equipment & Supplies7.51%
- Insurance0.99%
Each sector links to the mutual funds most exposed to it.
Thinking about DSP Healthcare Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
portfolio shared with DSP Healthcare Fund - Regular Plan - IDCW
- 1Ipca Laboratories Limited8.74%
- 2Sun Pharmaceutical Industries Limited7.95%
- 3Sai Life Sciences Limited7.45%
- 4Cipla Limited7.35%
- 5Apollo Hospitals Enterprise Limited6.47%
- 6Gland Pharma Limited5.98%
- 7Globus Medical Inc5.44%
- 8Divi'S Laboratories Limited4.15%
- 9Alkem Laboratories Limited4.08%
- 10Cohance Lifesciences Limited3.81%
What this fund does
DSP Healthcare Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
DSP Healthcare Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by DSP Mutual Fund. The fund has been operational for over 7 years. The current expense ratio is 0.75%.